Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (291-300 of 367) with videos related to

Pageof 37
Sort By:
Lancet (London, England)|December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialJohn F Forbes, Ivana Sestak, Anthony Howell, et al.
The Lancet. Oncology|December 20, 2011
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trialDorien C Rijkaart, Johannes Berkhof, Lawrence Rozendaal, et al.
Journal of Clinical Microbiology|March 17, 2012
Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 studyAnne Szarewski, David Mesher, Louise Cadman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2013
Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalitiesDavid Mesher, Anne Szarewski, Louise Cadman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2017
Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral PopulationJack Cuzick, Louise Cadman, Amar S Ahmad, et al.
Plos One|July 21, 2021
Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican womenRubí Hernández-López, Luis Hermosillo, Leith León-Maldonado, et al.
The Lancet. Oncology|July 4, 2006
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trialGuglielmo Ronco, Paolo Giorgi-Rossi, Francesca Carozzi, et al.
BMC Infectious Diseases|September 3, 2016
Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, MexicoSamantha E Rudolph, Attila Lorincz, Cosette M Wheeler, et al.
International Journal of Cancer|November 1, 2008
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderChris J L M Meijer, Johannes Berkhof, Philip E Castle, et al.
The Lancet. Oncology|December 25, 2012
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trialFrancesca Carozzi, Anna Gillio-Tos, Massimo Confortini, et al.
Pageof 37

Showing results (291-300 of 367) with videos related to

Sort By:
Pageof 37
Lancet (London, England)|December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialJohn F Forbes, Ivana Sestak, Anthony Howell, et al.
The Lancet. Oncology|December 20, 2011
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trialDorien C Rijkaart, Johannes Berkhof, Lawrence Rozendaal, et al.
Journal of Clinical Microbiology|March 17, 2012
Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 studyAnne Szarewski, David Mesher, Louise Cadman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2013
Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalitiesDavid Mesher, Anne Szarewski, Louise Cadman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2017
Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral PopulationJack Cuzick, Louise Cadman, Amar S Ahmad, et al.
Plos One|July 21, 2021
Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican womenRubí Hernández-López, Luis Hermosillo, Leith León-Maldonado, et al.
The Lancet. Oncology|July 4, 2006
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trialGuglielmo Ronco, Paolo Giorgi-Rossi, Francesca Carozzi, et al.
BMC Infectious Diseases|September 3, 2016
Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, MexicoSamantha E Rudolph, Attila Lorincz, Cosette M Wheeler, et al.
International Journal of Cancer|November 1, 2008
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderChris J L M Meijer, Johannes Berkhof, Philip E Castle, et al.
The Lancet. Oncology|December 25, 2012
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trialFrancesca Carozzi, Anna Gillio-Tos, Massimo Confortini, et al.
Pageof 37